We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$6.78B
AUM Growth
+$393M
Cap. Flow
-$49.7M
Cap. Flow %
-0.73%
Top 10 Hldgs %
31.83%
Holding
565
New
29
Increased
128
Reduced
269
Closed
29

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$41.1M
2
NOW icon
ServiceNow
NOW
+$19.2M
3
HUBB icon
Hubbell
HUBB
+$18.4M
4
WMT icon
Walmart Inc
WMT
+$11.3M
5
DE icon
Deere & Co
DE
+$3.97M

Top Sells

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$42.3M
2
FISV
Fiserv Inc
FISV
+$19.4M
3
SHW icon
Sherwin-Williams
SHW
+$10.9M
4
BSX icon
Boston Scientific
BSX
+$10.4M
5
UNH icon
UnitedHealth
UNH
+$8.97M

Sector Composition

Rank Sector Weight
1 Technology 23.73%
2 Financials 13.83%
3 Healthcare 11.89%
4 Industrials 11.66%
5 Communication Services 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
526
Agilent Technologies
A
$42B
$211K ﹤0.01%
1,647
-325
-16% -$39.3K
AGM icon
527
Federal Agricultural Mortgage
AGM
$2.54B
$211K ﹤0.01%
1,256
-119
-9% -$22.3K
AI icon
528
C3.ai
AI
$1.62B
$207K ﹤0.01%
+11,912
New +$249K
WST icon
529
West Pharmaceutical
WST
$24.8B
$205K ﹤0.01%
+781
New +$190K
DEO icon
530
Diageo
DEO
$54B
$204K ﹤0.01%
2,137
TY icon
531
TRI-Continental Corp
TY
$1.91B
$203K ﹤0.01%
+5,963
New +$197K
ELV icon
532
Elevance Health
ELV
$86.2B
$201K ﹤0.01%
622
VOE icon
533
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
$201K ﹤0.01%
1,150
-128
-10% -$21.8K
TMSL icon
534
T. Rowe Price Small-Mid Cap ETF
TMSL
$2.91B
$200K ﹤0.01%
+5,693
New +$194K
BALY icon
535
Bally's
BALY
$637M
$118K ﹤0.01%
10,600
-141,101
-93% -$1.42M
CGTX icon
536
Cognition Therapeutics
CGTX
$99.8M
$15.8K ﹤0.01%
11,722
ANIX icon
537
Anixa Biosciences
ANIX
$111M
-20,263
Closed -$66.9K
ANSS
538
DELISTED
Ansys
ANSS
-22,979
Closed -$8.07M
AVY icon
539
Avery Dennison
AVY
$13.5B
-1,270
Closed -$223K
BXSL icon
540
Blackstone Secured Lending
BXSL
$5.66B
-17,000
Closed -$523K
CFG icon
541
Citizens Financial Group
CFG
$30.6B
-4,797
Closed -$215K
CHE icon
542
Chemed
CHE
$7.18B
-416
Closed -$203K
DES icon
543
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
-6,692
Closed -$213K
DGRO icon
544
iShares Core Dividend Growth ETF
DGRO
$43.7B
-3,378
Closed -$216K
DRI icon
545
Darden Restaurants
DRI
$24.9B
-1,003
Closed -$219K
DXCM icon
546
DexCom
DXCM
$33.1B
-2,531
Closed -$221K
EDIV icon
547
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
-5,273
Closed -$201K
ESMV icon
548
iShares ESG Optimized MSCI USA Min Vol Factor ETF
ESMV
$7.92M
-6,931
Closed -$200K
FANG icon
549
Diamondback Energy
FANG
$55.7B
-7,487
Closed -$1.03M
FDS icon
550
Factset
FDS
$10.1B
-618
Closed -$276K

Similar funds

Bradley Foster & Sargent's Q3 2025 Portfolio in Review

As of Q3 2025, Bradley Foster & Sargent held 565 positions worth $6.78B, up 6.1% from $6.39B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bradley Foster & Sargent's Q3 2025 filing shows 29 new, 128 increased, 269 reduced and 29 closed positions. Its largest new stake was TechnipFMC: 48,132 shares worth $1.9M. The largest sale was Ball Corp, an estimated $42.3M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Bradley Foster & Sargent's largest Q3 2025 buy was TechnipFMC: 48,132 shares worth $1.9M.
  • Bradley Foster & Sargent added most to Boeing in Q3 2025, an estimated $41.1M increase.
  • Bradley Foster & Sargent's biggest Q3 2025 reduction was Ball Corp, cutting an estimated $42.3M.
  • Bradley Foster & Sargent fully exited Ansys in Q3 2025, selling an estimated $8.07M.
  • Bradley Foster & Sargent's ten largest holdings make up 32% of its $6.78B portfolio in Q3 2025.
  • Bradley Foster & Sargent opened 29 new positions and closed 29 in Q3 2025.
  • Bradley Foster & Sargent's portfolio value rose 6.1% quarter-over-quarter to $6.78B.

Based on Bradley Foster & Sargent's 13F filing for Q3 2025, filed 10 Nov 2025.